Tuberculosis News and Research

Latest Tuberculosis News and Research

LJI scientists uncover clues to how human T cells combat Mycobacterium tuberculosis

La Jolla Institute for Immunology (LJI) is working to guide the development of new tuberculosis vaccines and drug therapies.

6 Feb 2024

Closing the Cancer Care Gap with the Power of Precision Oncology

According to American Cancer Society, Cancer causes about 1 in every 6 deaths globally, more than AIDS, tuberculosis, and malaria combined.

From MGI 5 Feb 2024

Welch Foundation grant supports UTA research on drug-resistant tuberculosis

With a $300,000 grant, the Welch Foundation is supporting University of Texas at Arlington research into why some types of Mycobacterium tuberculosis (Mtb), the bacteria that causes the lung disease tuberculosis (TB), do not respond to treatments.

2 Feb 2024

Study sheds light on how serious people find COVID-19 compared to other health problems

A large seven-country study has shed light on how serious people find the COVID-19 pandemic compared to other major public health problems.

27 Jan 2024

UKHSA unveils groundbreaking Pathogen Genomics Strategy for pandemic preparedness

The UK Health Security Agency (UKHSA) has today published its Pathogen Genomics Strategy, laying out a 5 year plan for the organization's role in the wider delivery of pathogen genomics to prepare for and respond to infectious disease threats to public health.

24 Jan 2024

New mobile app proves effective in enhancing TB drug adherence

Mobile phone application called Gamified-Real-Time Video Observed Therapy or GRVOTS.

24 Jan 2024

Unveiling hidden TB risk with cutting-edge techniques

A novel approach to studying the progression of tuberculosis (TB) from infection to disease has identified and treated people at increased risk of developing the disease that current methods of testing would not.

22 Jan 2024

Nutrition's pivotal role in combating tuberculosis: addressing N-AIDS for better outcomes

Review highlights the critical role of nutritionally acquired immunodeficiency syndrome (N-AIDS) in tuberculosis (TB) management, emphasizing the need for integrated nutritional screening and care in TB programs.

18 Jan 2024

Prior mycobacterium exposure remodels immune cells, impacting tuberculosis defense

Tuberculosis, caused by the bacterium Mycobacterium tuberculosis (Mtb) kills upwards of 1.6 million people a year, making it one of the leading causes of death by an infectious agent worldwide-;and that number is only growing larger.

18 Jan 2024

Study reveals intestinal helminth infection diminishes T cell response to COVID-19 mRNA vaccine

Study investigates the impact of helminth infection on COVID-19 mRNA vaccine efficacy, revealing that while antibody responses remain largely unaffected, T-cell responses are significantly impaired, particularly against Omicron variants.

17 Jan 2024

International research collaboration leads to breakthrough in antibiotic resistance testing using DNA sequencing

The accuracy of antibiotic resistance determination from Enterococcus faecium genomes for diagnostic purposes.

15 Jan 2024

Leveraging nutritional interventions for effective TB control

Tuberculosis (TB) is the leading infectious killer worldwide, with 10.6 million cases and 1.6 million deaths in 2021 alone.

13 Jan 2024

BCG vaccine's impact on innate immunity explained at cellular level

Bacillus Calmette-Guérin (BCG) is one of the world’s oldest and most widely used vaccines. It was developed in the early 20th century to provide protection from tuberculosis.

9 Jan 2024

Disease-causing bacteria use molecular "barcode" to distinguish between beneficial and toxic molecules

Researchers at McMaster University have discovered a molecular "barcode" system used by disease-causing bacteria to distinguish between beneficial and toxic molecules.

8 Jan 2024

Sesame protein-derived peptides show promise in fighting E. coli and S. aureus

A study in "Nutrients" reveals that sesame protein-derived peptides, Ala-Gly-Gly-Val-Pro-Arg and Ser-Thr-Ile-Arg, show effective antibacterial activity against Escherichia coli and Staphylococcus aureus.

7 Jan 2024

St. Jude scientists develop novel spectinomycin derivatives to combat Mycobacterium abscessus

Scientists at St. Jude Children's Research Hospital are tackling Mycobacterium abscessus (Mab) antibiotic resistance.

5 Jan 2024

Scientists unearth dual-action weapons against deadly tuberculosis

A research team has detected various substances that have a dual effect against tuberculosis: They make the bacteria causing the disease less pathogenic for human immune cells and boost the activity of conventional antibiotics / publication in ‘Cell Chemical Biology’.

4 Jan 2024

Researchers receive two grants to study tuberculosis drug development

Weill Cornell Medicine researchers and the TB Drug Accelerator have received two grants totaling $6.8 million from the Bill & Melinda Gates Foundation to study tuberculosis (TB) drug development.

26 Dec 2023

Shedding new light on the evolution of tuberculosis

Recent research suggests that the emergence of tuberculosis infection in human populations dates back tens of thousands of years earlier than previously known cases in the Middle East.

26 Dec 2023

Brazilian researchers create cutting-edge nanoparticle weapon against tuberculosis

A low-cost technology involving nanoparticles loaded with antibiotics and other antimicrobial compounds that can be used in multiple attacks on infections by the bacterium responsible for most cases of tuberculosis has been developed by researchers at São Paulo State University (UNESP) in Brazil and is reported in an article published in the journal Carbohydrate Polymers.

20 Dec 2023

Tuberculosis News and Research

Latest Tuberculosis News and Research

LJI scientists uncover clues to how human T cells combat Mycobacterium tuberculosis

Closing the Cancer Care Gap with the Power of Precision Oncology

Welch Foundation grant supports UTA research on drug-resistant tuberculosis

Study sheds light on how serious people find COVID-19 compared to other health problems

UKHSA unveils groundbreaking Pathogen Genomics Strategy for pandemic preparedness

New mobile app proves effective in enhancing TB drug adherence

Unveiling hidden TB risk with cutting-edge techniques

Nutrition's pivotal role in combating tuberculosis: addressing N-AIDS for better outcomes

Prior mycobacterium exposure remodels immune cells, impacting tuberculosis defense

Study reveals intestinal helminth infection diminishes T cell response to COVID-19 mRNA vaccine

International research collaboration leads to breakthrough in antibiotic resistance testing using DNA sequencing

Leveraging nutritional interventions for effective TB control

BCG vaccine's impact on innate immunity explained at cellular level

Disease-causing bacteria use molecular "barcode" to distinguish between beneficial and toxic molecules

Sesame protein-derived peptides show promise in fighting E. coli and S. aureus

St. Jude scientists develop novel spectinomycin derivatives to combat Mycobacterium abscessus

Scientists unearth dual-action weapons against deadly tuberculosis

Researchers receive two grants to study tuberculosis drug development

Shedding new light on the evolution of tuberculosis

Brazilian researchers create cutting-edge nanoparticle weapon against tuberculosis

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Tuberculosis News and Research

Latest Tuberculosis News and Research

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Newsletters you may be interested in